5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
Yoshikawa T, Terashima M, Mizusawa J, Nunobe S, Nishida Y, Yamada T, Kaji M, Nomura T, Hato S, Choda Y, Yabusaki H, Yoshida K, Misawa K, Masuzawa T, Tsuda M, Kawachi Y, Katayama H, Fukuda H, Kurokawa Y, Boku N, Sano T, Sasako M.
Yoshikawa T, et al. Among authors: yamada t.
Gastric Cancer. 2024 Jan;27(1):155-163. doi: 10.1007/s10120-023-01447-5. Epub 2023 Nov 21.
Gastric Cancer. 2024.
PMID: 37989806
Clinical Trial.